| Address: | 3500 Barranca Pkwy #315, Irvine, CA 92606, USA |
|---|---|
| Postal code: | 92606 |
| Phone: | (949) 679-3889 |
| Monday: | 9:00 AM – 5:00 PM |
|---|---|
| Tuesday: | 9:00 AM – 5:00 PM |
| Wednesday: | 9:00 AM – 5:00 PM |
| Thursday: | 9:00 AM – 5:00 PM |
| Friday: | 9:00 AM – 5:00 PM |
| Saturday: | Closed |
| Sunday: | Closed |
There are no reviews yet!
You can review this Business and help others by leaving a comment. If you want to share your thoughts about Irvine Stem Cell Treatment Center, use the form below and your opinion, advice or comment will appear in this space.
Please RSVP at (949) 679-3889. The Irvine Stem Cell Treatment Center (Irvine, Westlake Village, and Sacramento, California), along with sister affiliates, the
Please RSVP at (949) 679-3889. The Irvine Stem Cell Treatment Center (Irvine, Westlake Village, and Sacramento, California), along with sister affiliates, the
Westlake Village, CA and Oxnard, CA (PRWEB) August 11, 2015 The Irvine Stem Cell Treatment Center announces a series of free public seminars on the use of adult stem cells for various degenerative and inflammatory conditions.
Information about Irvine Stem Cell Treatment Center, Newport Beach, CA.
Dr. Thomas A. Gionis. Free public seminars on the use of adult stem cells for several degenerative and inflammatory conditions, such as rheumatoid arthritis, are being offered by the Irvine Stem Cell Treatment Center throughout January.
The Irvine Stem Cell Treatment Center only uses autologous stem cells from a person's own fat - no embryonic stem cells are used. ... (949) 679-3889, or see a complete list of the Center's study ...
Thomas A. Gionis, MD JD MPH MBA MHA LLM FAIHQ Surgeon-in-Chief, Irvine Stem Cell Treatment Center United States Fulbright Scholar Fellow, American Institute for Healthcare Quality
Our new office is located at the New Body MD Surgical Center, 1111 Exposition Blvd., Suite 400B, Sacramento, CA 95815. If you have any questions or would like further information please call us at (949) 679-3889.
Manchester scientists have a developed a new method to monitor the effect of anti-cancer drugs on very rare leukemia stem cells. The approach potentially allows doctors to screen patients and personalise their treatment.